ClearPoint Neuro, Inc. (CLPT)
NASDAQ: CLPT · Real-Time Price · USD
11.08
-0.13 (-1.16%)
At close: Apr 28, 2026, 4:00 PM EDT
11.05
-0.03 (-0.27%)
After-hours: Apr 28, 2026, 7:08 PM EDT
ClearPoint Neuro Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Revenue | 36.97 | 31.39 | 23.96 | 20.55 | 16.3 | |
| Revenue Growth (YoY) | 17.78% | 31.04% | 16.56% | 26.09% | 27.05% | |
| Cost of Revenue | 14.28 | 12.27 | 10.34 | 7.02 | 5.18 | |
| Gross Profit | 22.69 | 19.12 | 13.61 | 13.53 | 11.12 | |
| Selling, General & Admin | 31.16 | 26.46 | 24.35 | 18.97 | 15.22 | |
| Research & Development | 13.9 | 12.39 | 11.71 | 10.89 | 9.28 | |
| Operating Expenses | 45.06 | 38.86 | 36.06 | 29.86 | 24.5 | |
| Operating Income | -22.36 | -19.73 | -22.45 | -16.33 | -13.37 | |
| Interest Expense | -2.39 | -0.52 | - | -0.08 | -0.97 | |
| Interest & Investment Income | 1.21 | 1.39 | 0.39 | - | - | |
| Other Non Operating Income (Expenses) | -0.15 | -0.04 | -0.03 | -0.02 | -0.06 | |
| EBT Excluding Unusual Items | -23.69 | -18.9 | -22.09 | -16.44 | -14.41 | |
| Merger & Restructuring Charges | -1.8 | - | - | - | - | |
| Pretax Income | -25.49 | -18.9 | -22.09 | -16.44 | -14.41 | |
| Income Tax Expense | 0.06 | 0.01 | - | - | - | |
| Net Income | -25.54 | -18.91 | -22.09 | -16.44 | -14.41 | |
| Net Income to Common | -25.54 | -18.91 | -22.09 | -16.44 | -14.41 | |
| Shares Outstanding (Basic) | 28 | 27 | 25 | 24 | 21 | |
| Shares Outstanding (Diluted) | 28 | 27 | 25 | 24 | 21 | |
| Shares Change (YoY) | 4.76% | 9.84% | 1.75% | 16.63% | 30.82% | |
| EPS (Basic) | -0.90 | -0.70 | -0.90 | -0.68 | -0.69 | |
| EPS (Diluted) | -0.90 | -0.70 | -0.90 | -0.68 | -0.69 | |
| Free Cash Flow | -24.45 | -9.23 | -14.44 | -16.42 | -12.87 | |
| Free Cash Flow Per Share | -0.86 | -0.34 | -0.59 | -0.68 | -0.62 | |
| Gross Margin | 61.38% | 60.92% | 56.83% | 65.84% | 68.24% | |
| Operating Margin | -60.49% | -62.87% | -93.70% | -79.47% | -82.05% | |
| Profit Margin | -69.08% | -60.26% | -92.21% | -79.97% | -88.41% | |
| Free Cash Flow Margin | -66.13% | -29.39% | -60.27% | -79.90% | -78.93% | |
| EBITDA | -21.48 | -18.75 | -21.82 | -16.09 | -13.22 | |
| EBITDA Margin | -58.10% | -59.75% | -91.09% | -78.28% | -81.08% | |
| D&A For EBITDA | 0.88 | 0.98 | 0.63 | 0.24 | 0.16 | |
| EBIT | -22.36 | -19.73 | -22.45 | -16.33 | -13.37 | |
| EBIT Margin | -60.49% | -62.87% | -93.70% | -79.47% | -82.05% | |
| Revenue as Reported | 36.97 | 31.39 | 23.96 | 20.55 | 16.3 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.